In summary, a high expression of SERPINE1 is a poor prognostic marker in head and neck squamous cell carcinoma patients that increases the risk of metastatic recurrences after therapy, possibly due to an increase in tumor cell migration and in resistance to cisplatin. The gene discussed is SERPINE1; the disease is neoplasm.